PsyBio Therapeutics Financing Inc.: PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Corporate Update

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 5, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology

Related Keywords

Ohio ,United States ,Canada ,Denver ,Colorado ,Canadian ,Nitin Kaushal ,Michael Spigarelli ,Bob Oliver ,Noah Davis ,Evan Levine ,Cross Carmel ,Company The Units ,Psybio Therapeutics Corp ,Drug Administration ,Venture Exchange ,Regulation Services Provider ,Colorado Newsfile Corp ,Bio Therapeutics ,Each Unit ,Current Good Manufacturing Practices ,Chief Executive ,Chief Medical ,Investigational New Drug ,United States Food ,Multilateral Instrument ,Minority Security Holders ,Special Transactions ,United States Securities Act ,Additional Offering ,Psybio Therapeutics ,Psybio ,Herapeutics ,Financing ,Nnounces ,Closing ,First ,Tranche ,Private ,Placement ,Chairman ,Chief ,Executive ,Officer ,Participation ,Rom ,Entire ,Board ,Directors ,Management ,Team ,Rovides , ,